Exploring the potential of stem cells and their regenerative capacity has been a core focus of medical research in Canada and Australia for many years. Recognizing the need to accelerate the translation of such findings into real benefits has led the Toronto-based Centre for Commercialization of Regenerative Medicine (CCRM) to join forces with Stem Cells Australia, a consortium of Australian researchers from leading universities and research organizations across the country.
CCRM and the Stem Cells Australia consortium have entered into a Memorandum of Understanding (MOU) to work together to increase the translation of stem cell research in the two countries to build an international cluster of scientific excellence. The MOU between the two organizations is an opportunity to flow new IP (intellectual property) through CCRM’s due diligence process that may complement existing technologies CCRM is reviewing for licensing or bundling into new company creations. The agreement formalizes CCRM’s previous relationship with one group of Australian researchers and also gives other consortium members the means to interact with CCRM and access its business development expertise and development capabilities.
By working together, CCRM and Stem Cells Australia will accelerate the translation of stem cell research into new research tools and cellular therapies and identify new opportunities for investment.
The Canadian Trade Commissioner Service based in Sydney, Australia has supported the CCRM in their efforts to broaden their network of contacts in Australia and showcase their unique capabilities.